SNAI1 and breast carcinoma: This indicates that miR-153 and its influence on the Snail pathway may serve as a novel therapeutic target for chemotherapy resistance and as a preventative mechanism of reducing cancer metastasis [56] in a variety of cancers including laryngeal squamous carcinoma [57], malignant melanoma [58], lung cancer [59] and breast cancer [60].